Akèy › Obèsite › Utah › Salt Lake City
Etid klinik pou Obèsite nan Salt Lake City, UT
18 etid pou Obèsite ap chèche patisipan nan sit nan ak bò kote Salt Lake City (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
Ap rekriteFaz 3
- Pantheon Clinical Research, Bountiful · 9 mi lwen
Partnership to Reduce Obesity in Community Health Center Patients (SMARTLife Utah)
Ap rekrite
- Huntsman Cancer Institute at the University of Utah, Salt Lake City
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Ap rekriteFaz 3
- AURORA-2 Clinical Site, Salt Lake City
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
Ap rekriteFaz 3
- AURORA-1 Clinical Site, Salt Lake City
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
Ap rekriteFaz 3
- George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Ap rekriteFaz 3Volontè an sante akeyi
- ACCOMPLISH-2 Research Site, Salt Lake City
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
Ap rekriteFaz 3
- Kailera Clinical Site, Salt Lake City
Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
Ap rekriteFaz 3
- Kailera Clinical Site, Salt Lake City
A Study of LY4174794 in Participants With Obesity or Overweight Who Are Otherwise Healthy
Ap rekriteFaz 1Volontè an sante akeyi
- ICON Early Phase Services, LLC, Salt Lake City
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
Ap rekriteFaz 3
- Research Site, Salt Lake City
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
Ap rekriteFaz 2
- Primary Children's Hospital, Salt Lake City
Circadian Intervention to Improve Cardiometabolic Health
Ap rekriteVolontè an sante akeyi
- College of Health Research Complex--University of Utah, Salt Lake City
Effect of Sleep Extension on Ceramides in People With Overweight and Obesity
Ap rekriteVolontè an sante akeyi
- College of Health Research Complex--University of Utah, Salt Lake City
Sit Less, Interact and Move More (SLIMM) 2 Study
Ap rekriteFaz 2
- University of Utah, Salt Lake City
Testing a Tailored Approach to Long-Term Weight Loss Success
Ap rekriteVolontè an sante akeyi
- University of Utah, Salt Lake City
A Study of RM-718 in Healthy Subjects and Patients With MC4R Pathway Impairment
Ap rekriteFaz 1/2Volontè an sante akeyi
- University of Utah Pediatric Endocrine Clinic (Part C and Part D), Salt Lake City
PreventT2 Together: Examining the Efficacy of Couple-based Lifestyle Intervention to Prevent Type 2 Diabetes
Ap rekriteVolontè an sante akeyi
- University of Utah, Salt Lake City
The Acute T-Rex (Timing of Resistance Exercise) Study
Ap rekrite
- University of Utah HPER E Buildling, Salt Lake City
Etid Obèsite nan lòt vil
- Houston, TX43 etid
- Chicago, IL41 etid
- New York City, NY40 etid
- San Antonio, TX40 etid
- Washington, DC33 etid
- Orlando, FL32 etid
- Dallas, TX30 etid
- Boston, MA28 etid
- Las Vegas, NV27 etid
- Miami, FL27 etid
- Baltimore, MD26 etid
- Jacksonville, FL25 etid
Lòt etid nan Salt Lake City
- Kansè Poumon ki pa ti selil31 etid
- Kansè (tout kalite)27 etid
- Kansè nan tete27 etid
- Kansè kolorektal22 etid
- Kansè poumon21 etid
- Melanom21 etid
- Myelom Miltip21 etid
- Kansè Metastatik20 etid
- Kansè ovè19 etid
- Leksemi mieloïd egi17 etid
- Ensifizyans kadyak17 etid
- Kansè pwostat15 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.